Using these approaches, we developed a comprehensive understanding of the role of microenvironmental immune regulation of CXCL12 in AF, and suggested that CXCL12 might be a marker for distinguishing AF subsets. The gene discussed is CXCL12; the disease is atrial fibrillation.